Clinical Trial

A Long-term Follow-up Study of Patients Who Received MB-105

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is to fulfil the regulatory requirement for 15-year follow-up for patients treated with MB-105 in any study
Trial Details
NCT Number NCT07340814
Lead Sponsor March Biosciences Inc
Conditions Any Patient Treated With MB-105
Enrollment 40 participants
Start Date 2026-02-27
Primary Completion 2040-10-15 (estimated)
Study Completion 2040-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-01-14